For years, we’ve known about how antibiotic resistant infections can damage our bodies and lead to huge expenses across the health care ecosystem. An Austin company is hoping to make a big difference on this front.

Pattern Bioscience Inc. uses single-cell microbiology technology that doesn’t require lengthy timeframes for bacteria to culture and quickly gives doctors the information they need to prescribe effective antibiotics. The company’s initial targets are for critically ill patients with pneumonia…

[wpcode id="4722"]

[zmauto id = 1]